Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction

Journal of Physiology

Volumn 592, Issue 13, 2014, Pages 2881-2897

  Ghazanfari, Nazanin ^a   Morsch, Marco ^a   Reddel, Stephen W ^b   Liang, Simon X ^c   Phillips, William D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; AUTOANTIBODY; BETA DYSTROGLYCAN; CHOLINERGIC RECEPTOR; MUSCLE SPECIFIC KINASE AUTOANTIBODIES; PROTEIN TYROSINE KINASE; RAPSYN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; MUSCLE PROTEIN; MUSK PROTEIN, MOUSE; PERIPHERAL MEMBRANE PROTEIN 43K;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENDPLATE POTENTIAL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE CELL; NEUROMUSCULAR SYNAPSE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SARCOLEMMA; SIGNAL TRANSDUCTION; STEADY STATE; TIBIALIS ANTERIOR MUSCLE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; MYASTHENIA GRAVIS; NERVE ENDING; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MOTOR ENDPLATE; MUSCLE PROTEINS; MYASTHENIA GRAVIS; PROTEIN TRANSPORT; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; SRC-FAMILY KINASES;

EID: 84903544751     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.270207     Document Type: Article

References (86)

1. Akaaboune M, Culican SM, Turney SG & Lichtman JW (1999). Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 286, 503-507.
2. Akaaboune M, Grady RM, Turney S, Sanes JR & Lichtman JW (2002). Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands. Neuron 34, 865-876.
3. Apel ED, Roberds SL, Campbell KP & Merlie JP (1995). Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 15, 115-126.
4. Ayalon G, Davis JQ, Scotland PB & Bennett V (2008). An ankyrin-based mechanism for functional organization of dytrophin and dystroglycan. Cell 135, 1189-1200.
5. Bartoli M, Ramarao MK & Cohen JB (2001). Interactions of the rapsyn RING-H2 domain with dystroglycan. J Biol Chem 276, 24911-24917.
6. Bergamin E, Hallock PT, Burden SJ & Hubbard SR (2010). The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. Mol Cell 39, 100-109.
7. Bezakova G & Bloch RJ (1998). The zinc finger domain of the 43-kDa receptor-associated protein, rapsyn: role in acetylcholine receptor clustering. Mol Cell Neurosci 11, 274-288.
8. Boggon TJ & Eck MJ (2004). Structure and regulation of Src family kinases. Oncogene 23, 7918-7927.
9. Borges LS & Ferns M (2001). Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering. J Cell Biol 153, 1-11.
10. Borges LS, Yechikov S, Lee YI, Rudell JB, Friese MB, Burden SJ & Ferns MJ (2008). Identification of a motif in the acetylcholine receptor β subunit whose phosphorylation regulates rapsyn association and postsynaptic receptor localization. J Neurosci 28, 11468-11476.
11. Bruneau E, Sutter D, Hume RI & Akaaboune M (2005). Identification of nicotinic acetylcholine receptor recycling and its role in maintaining receptor density at the neuromuscular junction in vivo. J Neurosci 25, 9949-9959.
12. Bruneau EG & Akaaboune M (2006). The dynamics of recycled acetylcholine receptors at the neuromuscular junction in vivo. Development 133, 4485-4493.
13. Cartaud A, Coutant S, Petrucci TC & Cartaud J (1998). Evidence for in situ and in vitro association between β-dystroglycan and the subsynaptic 43K rapsyn protein. J Biol Chem 273, 11321-11326.
14. Cheng A, Morsch M, Murata Y, Ghazanfari N, Reddel SW & Phillips WD (2013). Sequence of age-associated changes to the mouse neuromuscular junction and the protective effects of voluntary exercise. PLoS One 8, e67970.
15. Choi KR, Berrera M, Reischl M, Strack S, Albrizio A, Röder IV, Wagner A, Petersen Y, Hafner M, Zaccolo M & Rudolf R (2012). Rapsyn mediates subsynaptic anchoring of PKA type I and stabilisation of acetylcholine receptor in vivo. J Cell Sci 125, 714-723.
16. Christianson JC & Green WN (2004). Regulation of nicotinic receptor expression by the ubiquitin-proteosome system. EMBO J 23, 4156-4165.
17. Cole RN, Ghazanfari N, Ngo ST, Gervasio OL, Reddel SW & Phillips WD (2010). Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice. J Physiol 588, 3217-3229.
18. Cole RN, Reddel SW, Gervásio OL & Phillips WD (2008). Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann Neurol 63, 782-789.
19. Cote PD, Moukhles H, Lindenbaum M & Carbonetto S (1999). Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23, 338-342.
20. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
21. Finn AJ, Feng G & Pendergast AM (2003). Postsynaptic requirements for Abl kinases in assembly of the neuromuscular junction. Nat Neurosci 6, 717-723.
22. Friese MB, Blagden CS & Burden SJ (2007). Synaptic differentiation is defective in mice lacking acetylcholine receptor β-subunit tyrosine phosphorylation. Development 134, 4167-4176.
23. Fuhrer C, Gautam M, Sugiyama JE & Hall ZW (1999). Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors. J Neurosci 19, 6405-6416.
24. Fuhrer C & Hall ZW (1996). Functional interaction of Src family kinases with the acetylcholine receptor in C2 myotubes. J Biol Chem 271, 32474-32481.
25. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR & Merlie JP (1995). Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn deficient mice. Nature 377, 232-236.
26. Gervásio OL, Armson PF & Phillips WD (2007). Developmental increase in the amount of rapsyn per acetylcholine receptor promotes postsynaptic receptor packing and stability. Dev Biol 305, 262-275.
27. Gervásio OL & Phillips WD (2005). Increased ratio of rapsyn to ACh receptor stabilizes postsynaptic receptors at the mouse neuromuscular synapse. J Physiol 562, 673-685.
28. Glass DJ, Bowen DC, Stitt TN, Radiejewski C, Brunno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM & Yancopoulos GD (1996). Agrin acts via a MuSK receptor complex. Cell 85, 513-523.
29. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP & Sanes JR (2000). Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25, 279-293.
30. Higuchi O, Hamuro J, Motomura M & Yamanashi Y (2011). Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69, 418-422.
31. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A & Vincent A (2001). Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7, 365-368.
32. Hopf C & Hoch W (1998). Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes. J Biol Chem 273, 6467-6473.
33. Huebsch KA & Maimone MM (2003). Rapsyn-mediated clustering of acetylcholine receptor subunits requires the major cytoplasmic loop of the receptor subunits. J Neurobiol 54, 486-501.
34. Huijbers MG, Zhang W, Klooster R, Niks EH, Friese MB, Straasheijm IR, Thijssen PE, Vrolijk H, Plomp JJ, Vogels P, Losen M, van der Maarel SM, Burden SJ & Verschuuren JJ (2013). MuSK IgG4 auto-antibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A 110, 20783-20788.
35. Hyman C & Froehner SC (1983). Degradation of acteylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties. J Cell Biol 95, 1316-1324.
36. Jacobson C, Cote PD, Rossi SG, Rotundo RL & Carbonetto S (2001). The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152, 435-450.
37. Kahl J & Campanelli JT (2003). A role for the juxtamembrane domain of β-dystroglycan in agrin-induced acetylcholine receptor clustering. J Neurosci 23, 392-402.
38. Kawakami Y, Ito M, Hirayama M, Sahashi K, Ohkawara B, Masuda A, Nishida H, Mabuchi N, Engel AG & Ohno K (2011). Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology 77, 1-8.
39. Kim N & Burden SJ (2008). MuSK controls where motor axons grow and form synapses. Nat Neurosci 11, 19-27.
40. Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML & Burden SJ (2008). Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135, 334-342.
41. Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinex-Martinez P, De Baets MH, van der Maarel S & Verschuuren JJ (2012). Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 135, 1081-1101.
42. Koneczny I, Cossins J, Waters P, Beeson D & Vincent A (2013). MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-Independent AChR clusters. PLoS One 11, e80695.
43. le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F & Gamacorti-Passerini C (1999). In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J Natl Cancer Inst 91, 163-168.
44. Lee Y, Rudell J & Ferns M (2009). Rapsyn interacts with the muscle acetylcholine receptor via α-helical domains in the α, β, and ε subunit intracellular loops. Neuroscience 163, 222-232.
45. Lefebvre JL, Juing L, Becaficco S, Franzini-Armstrong C & Granato M (2007). Differential requirement for MuSK and dystroglycan in generating patterns of neuromuscular innervation. Proc Natl Acad Sci U S A 104, 2483-2488.
46. Losen M, Stassen MHW, Martinez-Martinez P, Machiels B, Duimel H, Frederik P, Veldman H, Wokke JHJ, Spaans F, Vincent A & DeBaets M (2005). Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain 128, 2327-2337.
47. Lu Z, Je H-S, Young P, Gross J, Lu B & Feng G (2007). Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction. J Cell Biol 177, 1077-1089.
48. McConville J, Farrugia ME, Beeson D, Kishore U, Metcalf R, Newsom-Davis J & Vincent A (2004). Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55, 580-584.
49. McMahan UJ & Slater CR (1984). The influence of basal lamina on the accumulation of acetylcholine receptors at synaptic sites in regenerating muscle. J Cell Biol 98, 1453-1473.
50. Mittaud P, Camilleri AA, Willmann R, Ern-Vogtli S, Burden SJ & Fuhrer C (2004). A single pulse of agrin triggers a pathway that acts to cluster acetylcholine receptors. Mol Cell Biol 24, 7841-7854.
51. Mittaud P, Marangi PA, Erb-Vogtli S & Fuhrer C (2001). Agrin-activation of acetylcholine receptor-bound src family kinases requires rapsyn and correlates with acetylcholine receptor clustering. J Biol Chem 276, 14505-14513.
52. Mohamed AS, Rivas-Plata KA, Kraas JR, Saleh SM & Swope SL (2001). Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering. J Neurosci 21, 3806-3818.
53. Montanaro F, Gee SH, Jacobson C, Lindenbaum MH, Froehner SC & Carbonetto S (1998). Laminin and α-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway. J Neurosci 18, 1250-1260.
54. Moransard M, Borges LS, Willmann R, Marangi PA, Brenner HR, Ferns MJ & Fuhrer C (2003). Agrin regulates rapsyn interaction with surface AChRs which underlies cytoskeletal anchoring and clustering. J Biol Chem 278, 7350-7359.
55. Mori S, Kubo S, Akiyoshi T, Yamada S, Miyazaki T, Hotta H, Desaki J, Kishi M, Konishi T, Nishino Y, Miyazawa A, Maruyama N & Shigemoto K (2012a). Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. Am J Pathol 180, 798-810.
56. Mori S, Yamada S, Kubo S, Chen J, Matsuda S, Shudou M, Maruyama N & Shigemoto K (2012b). Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis. J Neuroimmunol 244, 1-7.
57. Morsch M, Reddel SW, Ghazanfari N, Toyka KV & Phillips WD (2012). Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors. Exp Neurol 237, 286-295.
58. Morsch M, Reddel SW, Ghazanfari N, Toyka KV & Phillips WD (2013). Pyridostigmine but not 3, 4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. J Physiol 591, 2747-2762.
59. Ngo ST, Cole RN, Sunn N, Phillips WD & Noakes PG (2012). Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering via muscle-specific kinase phosphorylation. J Cell Sci 125, 1531-1543.
60. Niks EH, Kuks JBM, Wokke JHJ, Veldman H, Bakker E, Verschuuren JJGM & Plomp JJ (2010). Pre- and postsynaptic neuromuscular junction abnormalities in MuSK myasthenia. Muscle Nerve 42, 283-288.
61. Ohno K, Ito M, Kawakami Y & Ohtsuka K (2013). Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis. J Mol Neurosci DOI: 10.1007/s12031-013-0170-x.
62. Ohta K, Shigemoto K, Fujinami A, Maruyama N, Konishi T & Ohta M (2007). Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol 14, 1029-1034.
63. Peng HB & Froehner SC (1985). Association of the postsynaptic 43K protein with newly formed acetylcholine receptor clusters in cultured muscle cells. J Cell Biol 100, 1698-1705.
64. Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A & Kröger S (2011). Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259, 427-435.
65. Phillips WD, Noakes PG, Roberds SL, Campbell KP & Merlie JP (1993). Clustering and immobilization of acetylcholine receptors by the 43-kD protein: a role for dystrophin-related protein. J Cell Biol 123, 729-740.
66. Pilgram GSK, Potikanond S, Baines RA, Fradkin LG & Noordermeer JN (2010). The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 41, 1-21.
67. Pumplin DW & Bloch RJ (1987). Disruption and reformation of the acetylcholine receptor clusters of cultured rat myotubes occur in two distinct stages. J Cell Biol 104, 97-108.
68. Punga AR, Lin S, Oliveri F, Meinen S & Ruegg MA (2011). Muscle-selective synaptic disassembly and reorganization in MuSK antibody-positive MG mice. Exp Neurol 230, 207-217.
69. Ramarao MK, Bianchetta MJ, Lanken J & Cohen JB (2001). Role of rapsyn tetratrico repeat and coiled-coil domains in self association and nicotinic acetylcholine receptor clustering. J Biol Chem 276, 7475-7483.
70. Ramarao MK & Cohen JB (1998). Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc Natl Acad Sci U S A 95, 4007-4012.
71. Richman DP, Nishi K, Morell SW, Chang JM, Ferns MJ, Wollmann RL, Maselli RA, Schnier J & Agius MA (2011). Acute severe animal model of anti-muscle-specific kinase myasthenia. Arch Neurol 69, 453-460.
72. Röder IV, Choi K-R, Reischl M, Petersen Y, Diefenbacher ME, Zaccolo M, Pozzan T & Rudolf R (2010). Myosin Va cooperates with PKA RIα to mediate maintenance of the endplate in vivo. Proc Natl Acad Sci U S A 107, 2031-2036.
73. Sadasivam G, Willman R, Lin S, Erb-Vogtli S, Kong XC, Ruegg MA & Fuhrer C (2005). Src-family kinases stabilize the neuromuscular synapse via protein interactions, phosphorylation, and cytoskeletal linkage. J Neurosci 25, 10479-10493.
74. Schmidt N, Akaaboune M, Gajendran N, Martinez-Pena Y, Valenzuela I, Wakefield S, Thurnheer R & Brenner HR (2011). Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin. J Cell Biol 195, 1171-1184.
75. Selcen D, Fukuda T, Shen X-M & Engel AG (2004). Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 62, 1945-1950.
76. Shen C, Lu Y, Zhang B, Figueiredo D, Bean J, Jung J, Wu H, Barik A, Yin D-M, Xiong W-C & Mei L (2013). Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest 123, 5190-5202.
77. Shigemoto K, Kubo S, Maruyama N, Hato N, Yamada H, Jie C, Kobayashi N, Mominoki K, Abe Y, Ueda N & Matsuda S (2006). Induction of myasthenia by immunization against muscle-specific kinase. J Clin Invest 116, 1016-1024.
78. Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, Tsujihata M, Vincent A & Eguchi K (2005). Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 57, 289-293.
79. Stacy S, Gelb BE, Koop BA, Windle JJ, Wall KA, Krolick KA, Infante AJ & Kraig E (2002). Split tolerance in a novel transgenic model of autoimmune myasthenia gravis. J Immunol 169, 6570-6579.
80. Sugiyama JE, Glass DJ, Yancopoulos GD & Hall ZW (1997). Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol 139, 181-191.
81. Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH & Kao I (1977). Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296, 125-131.
82. Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R & Vincent A (2012). Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects. Exp Neurol 234, 506-512.
83. Weston C, Gordon C, Teressa G, Hod E, Ren X-D & Prives J (2003). Cooperative regulation by Rac and Rho of agrin-induced acetylcholine receptor clustering in muscle cells. J Biol Chem 278, 6450-6455.
84. Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC & Mei L (2008). LRP4 serves as a coreceptor of agrin. Neuron 60, 285-297.
85. Zhu D, Yang Z, Luo Z, Luo S, Xiong WC & Mei L (2008). Muscle-specific receptor tyrosine kinase endocytosis in acetylcholine receptor clustering in response to agrin. J Neurosci 28, 1688-1696.
86. Zubera B & Unwin N (2013). Structure and superorganization of acetylcholine receptor-rapsyn complexes. Proc Natl Acad Sci U S A 110, 10622-10627.